Imagine that it’s been three years since the completion of a trial, and that suddenly a regulatory body calls into question the findings:
- Was a particular trial site operating properly?
- Can you clarify an aspect of the results?
- Why did you make a particular decision at an interim look?
Suddenly, your somewhat old data needs to...